Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
Add more filters










Publication year range
1.
PLoS One ; 9(3): e91267, 2014.
Article in English | MEDLINE | ID: mdl-24614057

ABSTRACT

The late assembly domain of many viruses is critical for budding. Within these domains, encoded in viral structural proteins, are the conserved motifs PTAP, PPxY and YPxL. These sequences are the key determinants for association of viral proteins with intracellular molecules such as Tsg101, Nedd4 and AIP1/ALIX. While roles for Tsg101 and AIP1/ALIX in HIV-1 budding have been well established, less is known about the role of Nedd4. Recent studies, however, have identified a function for Nedd4-like protein in HIV-1 release. In this study, we investigated post-transcriptional changes of Nedd4 following SHIVSF162P3 infection of rhesus macaques, its role on HIV-1 p24 and gp120 levels in vitro and its potential as an immune modulator in HIV vaccination of BALB/c mice. Increased Nedd4 protein levels were noted in both CD4+ and CD8+ T cells following SHIVSF162P3-infection of naïve macaques. Transient co-transfection studies in 293 cells with HXB2 and Nedd4 demonstrated a Nedd4-mediated increase in p24 and gp120 levels. This increase was found to be dependent on the Ca2+/calmodulin-regulated phospholipid binding C2 domain and not ubiquitin ligase activity or HIV LTR activity. Co-transfection of Nedd4 with plasmid DNA expressing Gag or Env was further shown to augment both intracellular and extracellular Gag or Env proteins. To assess the potential of Nedd4 as an immune modulator, BALB/c mice were immunized intramuscularly with plasmid DNA encoding HIV gag, env and Nedd4. Nedd4 co-administration was found to increase serum anti-p24 but not anti-gp120 antibodies. Nedd4 co-injection was found to have no affect on Gag- or Env-specific IFNγ but had a trend of increased Gag-specific IL-6, IL-17A and TNFα that was not seen following Env stimulation. Based on our initial findings, Nedd4-mediated changes in HIV protein levels and its potential use in HIV-1 vaccine development warrants further investigation.


Subject(s)
Endosomal Sorting Complexes Required for Transport/metabolism , HIV-1/metabolism , Immunity , Ubiquitin-Protein Ligases/metabolism , Vaccination , Vaccines, DNA/immunology , env Gene Products, Human Immunodeficiency Virus/metabolism , gag Gene Products, Human Immunodeficiency Virus/metabolism , Animals , Calcium/metabolism , Calmodulin/metabolism , Endosomal Sorting Complexes Required for Transport/chemistry , Humans , Immunity, Cellular , Immunity, Humoral , Macaca mulatta/immunology , Macaca mulatta/virology , Mice, Inbred BALB C , Nedd4 Ubiquitin Protein Ligases , Promoter Regions, Genetic/genetics , Protein Structure, Tertiary , RNA, Small Interfering/metabolism , Simian Acquired Immunodeficiency Syndrome/metabolism , Simian Immunodeficiency Virus/immunology , Transfection , Ubiquitin-Protein Ligases/chemistry
2.
PLoS One ; 8(9): e73969, 2013.
Article in English | MEDLINE | ID: mdl-24023920

ABSTRACT

BACKGROUND: In humans it has been reported that a major site of the latent reservoir of HIV is within CD4+ T cells expressing the memory marker CD45RO, defined by the mAb UCHL1. There are conflicting reports regarding the expression of this antigen in macaques, the most relevant animal species for studying HIV pathogenesis and testing new therapies. There is now a major effort to eradicate HIV reservoirs and cure the infection. One approach is to eliminate subsets of cells housing the latent reservoir, using UCHL1 to target these cells. So that such studies may be performed in macaques, it is essential to determine expression of CD45RO. METHODS: We have used immunofluorescence and flow cytometry to study cell surface expression of CD45RO on lymphocytes from PBMC, lymphoid, and GI organs of rhesus, pigtailed, and cynomolgus macaques. Both direct and indirect immunofluorescence experiments were performed. FINDINGS: CD45RO is expressed on a subset of CD4+ lymphocytes of all pigtailed, a fraction of rhesus, and neither of the cynomolgus macaques studied. The binding of UCHL1 to macaque cells was of lower avidity than to human cells. This could be overcome by forming UCHL1 multimers. Directly conjugating fluors to UCHL1 can inhibit UCHL1 binding to macaque cells. Patterns of UCHL1 expression differ somewhat in macaques and humans, and from that of other memory markers often used in macaques. CONCLUSIONS: CD45RO, defined with mAb UCHL1, is well expressed on CD4+ cells in pigtailed macaques. Using tissues recovered from latently infected pigtailed macaques we are determining whether UCHL1, or other memory markers, can define the cellular locus of the reservoir. The low avidity of this interaction could limit the utility of UCHL1, in its conventional form, to eliminate cells in vivo and test this approach in macaque models of HIV infection.


Subject(s)
Gene Expression Regulation/immunology , Leukocyte Common Antigens/metabolism , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/metabolism , Adult , Animals , Antibodies, Monoclonal/immunology , Biomarkers/metabolism , Gene Expression Regulation/drug effects , Humans , Immunotoxins/toxicity , Macaca , T-Lymphocytes, Helper-Inducer/drug effects
3.
Vaccine ; 27(38): 5239-46, 2009 Aug 20.
Article in English | MEDLINE | ID: mdl-19591795

ABSTRACT

The Plasmodium falciparum apical membrane antigen 1 (AMA1) is a leading vaccine candidate and was tested for safety and immunogenicity in human Phase I Clinical Trials. PBMC from vaccine recipients were analyzed by flow cytometric methods to determine the nature of T-cell responses and AMA1-reactive memory T cells. Both CD4 and CD8 T cells produced a number of cytokines following AMA1 re-stimulation, with IL-5-producing cells at the highest frequency, consistent with a Th2 bias. The relative frequency of multifunctional cells synthesizing Th1 cytokines IFN-gamma, IL-2 and TNF-alpha changed after each vaccination. Interestingly, median fluorescence intensity measurements revealed that cells producing more than one cytokine contributed greater quantities of each cytokine than cell populations that produced each of the cytokines alone. AMA1 vaccination also elicited the development of memory cell populations, and both central and effector memory T cells were identified concurrently after the AMA1 vaccination. The detailed profile of multifunctional T-cell responses to AMA1 presented here will advance our ability to assess the immunogenicity of human malarial vaccines.


Subject(s)
Antigens, Protozoan/immunology , CD4-Positive T-Lymphocytes/immunology , Immunologic Memory , Malaria Vaccines/immunology , Malaria, Falciparum/prevention & control , Membrane Proteins/immunology , Plasmodium falciparum/immunology , Protozoan Proteins/immunology , Animals , Antibodies, Protozoan/blood , CD4-Positive T-Lymphocytes/metabolism , CD8-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/metabolism , Humans , Interferon-gamma/immunology , Interleukin-2/immunology , Interleukin-5/immunology , Tumor Necrosis Factor-alpha/immunology
4.
J Immunol ; 180(3): 1451-61, 2008 Feb 01.
Article in English | MEDLINE | ID: mdl-18209040

ABSTRACT

A number of blood-stage malaria Ags are under development as vaccine candidates, but knowledge of the cellular responses to these vaccines in humans is limited. We evaluated the nature and specificity of cellular responses in healthy American volunteers vaccinated with a portion of the major merozoite surface protein-1 (MSP1) of Plasmodium falciparum, MSP1(42), formulated on Alhydrogel. Volunteers were vaccinated three times with 80 microg of either MSP1(42)-FVO/Alhydrogel or MSP1(42)-3D7/Alhydrogel. Cells collected 2 wk after the third vaccination produced Th1 cytokines, including IFN-gamma and IL-2 following Ag stimulation, and greater levels of the Th2 cytokines IL-5 and IL-13; the anti-inflammatory cytokine IL-10 and the molecule CD25 (IL-2Ralpha) were also detected. The volunteers were evaluated for the MSP1(42)-FVO or MSP1(42)-3D7 specificity of their T cell responses. Comparison of their responses to homologous and heterologous Ags showed ex vivo IFN-gamma and IL-5 levels that were significantly higher to homologous rather than to heterologous Ags. The epitopes involved in this stimulation were shown to be present in the dimorphic MSP1(33) portion of the larger MSP1(42)-3D7 polypeptide, and indirect experiment suggests the same for the MSP1(42)-FVO polypeptide. This contrasts with B cell responses, which were primarily directed to the conserved MSP1(19) portion. Furthermore, we explored the maturation of memory T cells and found that 46% of vaccinees showed specific memory T cells defined as CD4(+)CD45RO(+)CD40L(+) after long-term in vitro culture. The identification of human-specific CD4(+) memory T cells provides the foundation for future studies of these cells both after vaccination and in field studies.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , Malaria Vaccines/immunology , Merozoite Surface Protein 1/immunology , Plasmodium falciparum/immunology , Alleles , Animals , Cytokines/immunology , Humans , Immunity, Cellular/genetics , Immunologic Memory , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-2 Receptor alpha Subunit/metabolism , Th1 Cells/immunology , Th2 Cells/immunology , Vaccination
5.
Am J Trop Med Hyg ; 76(5): 977-82, 2007 May.
Article in English | MEDLINE | ID: mdl-17488926

ABSTRACT

The performance of Fas2-ELISA for the diagnosis of Fasciola hepatica infection in children living in areas of high endemicity for fascioliasis in the Peruvian Andes is analyzed. Fas2-ELISA is based on the detection of circulating IgG antibodies elicited in infected individuals against a F. hepatica antigen termed Fas2. The study was conducted in three Andean localities, Huertas-Julcan in Junin, Asillo in Puno, and Cajamarca, with a total population of 634 children in an age range 1 to 16 years old. Child fascioliasis prevalence was 21.1% in Huertas-Julcan, 25.4% in Asillo, and 24% in Cajamarca, estimated by coprological inspection. The seroprevalence of F. hepatica infection, determined by Fas2-ELISA, was 27.8% in Huertas-Julcan, 44.6% in Asillo, and 29.1% in Cajamarca. The overall sensitivity of Fas2-ELISA was 92.4%, the specificity 83.6%, and the negative predictive value 97.2%. No association between OD(450) Fas2-ELISA and infection intensity measured by egg counting was observed. Results show that Fas2-ELISA is a highly sensitive immunodiagnostic test for the detection of F. hepatica infection in children living in human fascioliasis endemic areas.


Subject(s)
Antibodies, Helminth/blood , Antigens, Helminth/immunology , Cysteine Endopeptidases/immunology , Enzyme-Linked Immunosorbent Assay/methods , Fasciola hepatica/immunology , Fascioliasis/diagnosis , Adolescent , Age Factors , Animals , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/standards , Fascioliasis/epidemiology , Feces/parasitology , Female , Helminthiasis/epidemiology , Humans , Immunoglobulin G/blood , Infant , Intestines/parasitology , Male , Peru/epidemiology , Prevalence , Protozoan Infections/epidemiology , Risk Factors , Sensitivity and Specificity
6.
Am J Trop Med Hyg ; 71(1): 40-2, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15238686

ABSTRACT

The polymorphisms in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) and P. falciparum chloroquine resistance transporter (pfcrt) genes, which are associated with chloroquine resistance, were examined in 48 P. falciparum isolates from uncomplicated malaria patients from the West Lombok District in Indonesia. The point mutation N86Y in pfmdr1 was present in 35.4% of the isolates and mutation K76T in pfcrt was found in all but one of the samples studied. Identified pfcrt haplotypes were mainly identical to the Papua New Guinea type S(agt)VMNT (42 of 48, 87.5%), and a few isolates had the Southeast Asia type CVIET (5 of 48, 10.4%). Moreover, one P. falciparum isolate harbored the K76N mutation, giving rise to the haplotype CVMNN, which was not previously reported in field isolates. Our findings suggest that chloroquine resistance in this area might have the same origin as in Papua New Guinea.


Subject(s)
Chloroquine/pharmacology , Drug Resistance/genetics , Membrane Proteins/genetics , Plasmodium falciparum/genetics , Animals , DNA, Protozoan/chemistry , Haplotypes , Humans , Indonesia , Membrane Transport Proteins , Plasmodium falciparum/drug effects , Polymorphism, Genetic , Protozoan Proteins
7.
Am J Trop Med Hyg ; 70(5): 461-6, 2004 May.
Article in English | MEDLINE | ID: mdl-15155976

ABSTRACT

In vitro drug sensitivity to chloroquine (CQ), mefloquine (MQ) and quinine was investigated in 60 culture-adapted Plasmodium falciparum isolates from malaria patients in Padrecocha, a village in the Amazonian Department of Loreto, Peru. All isolates showed resistance to CQ, decreased susceptibility to quinine, and sensitivity to MQ. These isolates were examined for mutations in the P. falciparum multidrug resistance 1 (pfmdr1) and chloroquine resistance transporter (pfcrt) genes previously linked to CQ resistance. The mutations N86Y and D1246Y, two of the five mutations commonly observed in the pfmdr1 gene of CQ-resistant clones, were not found. The pfcrt mutation K76T, associated with CQ resistance, was identified in all the isolates tested. Sequence analysis of codons 72-76 in the pfcrt gene showed the haplotypes SVMNT and CVMNT.


Subject(s)
Antimalarials/pharmacology , Chloroquine/pharmacology , Genes, MDR , Membrane Proteins/genetics , Plasmodium falciparum/drug effects , Polymorphism, Genetic , Animals , Drug Resistance, Multiple , Genotype , Mefloquine/pharmacology , Membrane Transport Proteins , Mutation , Parasitic Sensitivity Tests , Plasmodium falciparum/genetics , Protozoan Proteins , Quinine/pharmacology
8.
Int J Parasitol ; 33(2): 175-83, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12633655

ABSTRACT

CD4(+) T cells co-expressing CD25 (CD4(+)CD25(+) T cells) have been identified as immunoregulatory suppressors modulating autoimmune response. Beside that, autoimmune response was supposed to be associated with malaria infection. Based on these data, we hypothesised that CD4(+)CD25(+) T cells may influence protective immunity to malaria parasites, while suppressing autoimmune response arising throughout the course of malarial infection. To test this possibility, we evaluated the kinetics of CD4(+)CD25(+) T cells during malaria infection and investigated the influence of CD25 depletion by anti-mouse CD25 monoclonal antibody (PC61) on the infection, using a mouse model of premunition to Plasmodium berghei NK65 malaria. The results showed that, during exacerbation of P. berghei NK65 infection, the proportion of CD4(+)CD25(+) T cells among CD4(+) T cells decreased, although that of CD4(+) T cells increased. CD25 depletion clearly delayed the growth of parasitaemia during parasite challenge, particularly in immunised mice. These findings demonstrated that CD4(+)CD25(+) T cells are able to influence protective immunity underlying premunition to P. berghei NK65 parasites.


Subject(s)
CD4 Antigens/immunology , CD4-Positive T-Lymphocytes/immunology , Malaria/immunology , Plasmodium berghei/immunology , Receptors, Interleukin-2/immunology , Animals , Antigens, Protozoan/immunology , Autoimmunity , CD4 Lymphocyte Count , Female , Immunization , Malaria/prevention & control , Mice , Mice, Inbred BALB C , Models, Animal
9.
Trans R Soc Trop Med Hyg ; 97(5): 535-8, 2003.
Article in English | MEDLINE | ID: mdl-15307419

ABSTRACT

Routine microscopical examination of stool specimens for diagnosis of strongyloidiasis is insensitive and serological methods using Strongyloides stercoralis antigen are at present not available for field studies. We evaluated 2 techniques, enzyme-linked immunosorbent assay (ELISA) and gelatin particle indirect agglutination (GPIA), using an antigen obtained from the rodent parasite, S. venezuelensis. Fifty-four Peruvian patients with different clinical forms of strongyloidiasis were studied: 12 asymptomatic, 31 symptomatic, and 11 hyperinfection cases. Our results demonstrate that both ELISA and GPIA using S. venezuelensis antigen are useful for diagnosis of strongyloidiasis, with sensitivities of 74.1% and 98.2%, respectively and a specificity of 100% for both techniques. We found that GPIA is a highly sensitive test for patients with suspected chronic infection and/or hyperinfection. In the hyperinfection cases, significantly lower concentrations of specific immunoglobulin antibodies and eosinophils (P < 0.001) were found compared with the asymptomatic and symptomatic cases.


Subject(s)
Agglutination Tests/methods , Enzyme-Linked Immunosorbent Assay/methods , Strongyloidiasis/diagnosis , Adolescent , Adult , Aged , Agglutination Tests/standards , Analysis of Variance , Animals , Antigens, Helminth/analysis , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/standards , HTLV-I Infections/complications , Humans , Middle Aged , Sensitivity and Specificity , Strongyloides/immunology , Strongyloides/isolation & purification
10.
Clin Diagn Lab Immunol ; 9(4): 933-4, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12093701

ABSTRACT

Antimalarial treatments during primary Plasmodium berghei NK65 infection in BALB/c mice influenced the acquisition of protective immunity against reinfection. Among subcurative treatments, lower doses better enable mice to acquire protective immunity than do higher doses. Eradication of parasites from the start of infection did not promote protective immunity.


Subject(s)
Antimalarials/administration & dosage , Immunity/drug effects , Malaria/drug therapy , Animals , Antimalarials/immunology , Dose-Response Relationship, Drug , Female , Malaria/immunology , Mice , Mice, Inbred BALB C , Parasitemia/immunology , Plasmodium berghei/growth & development
SELECTION OF CITATIONS
SEARCH DETAIL
...